Cryptococcosis is a life-threatening disease caused by the ubiquitous, encapsulated fungus, Cryptococcus neoformans. Although individuals with T cell deficiencies are the most susceptible group for this disease, normal individuals have been reported to have cryptococcosis. Without T cell function, the currently available antifungal drugs do not cure the disease. Consequently, it is desirable to develop immunomodulatory or immunoreplacement therapies; however, without sufficient understanding of the protective and nonprotective aspects of the hosts resistance mechanisms, it is impossible to develop successful immunotherapies. It is clear that certain aspects of the anticryptococcal cell-mediated immune (CMI) responses are protective; whereas others are not. Using an immunocompetent mouse model, we have found that two different immunogens induce anticryptococcal CMI responses that are detectable by delayed- type hypersensitivity (DTH), but one immunogen induces a profile of two functionally different activated CD4+ T cells and protection; whereas the other immunogen induces a different set of activated T cells including both CD4+ and CD8+ T cells and no protection. We propose to exploit these models of two different immune states to define the protective and nonprotective leukocytes, cytokines, chemokines and chemokine receptors. We have developed a murine model in which we implant gelatin sponges into immunized mice, and once the immune response is established then we inject the sponges with either saline (control) or specific antigen (DTH-reaction site). Over a period of 24 h after antigen injection, the DTH-reactive sponges display leukocyte infiltrates, cytokines and chemokines characteristic of a DTH reaction. We propose that the cellular and chemical events at this reaction site are similar to events at the site of infection in an immune host. Consequently by comparing the events occurring in DTH-reactive sponges in mice immunized to get a protective T cell profile with similar sponges in mice immunized to get a nonprotective T cell profile then we will be able to understand which combinations) of leukocytes, leukocyte receptors, cytokines, chemokines and chemokine receptors is necessary for protection and which of the components are associated with the nonprotective CMI response. Through the use of neutralization studies with antibodies and knockout mouse experiments, we plan to elucidate the interactions and codependence of the various components needed for protection against C neoformans. The information obtained from these studies will be useful for designing effective immunoreplacement and immunomodulatory therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI015716-20
Application #
2758859
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Dixon (Dmid), Dennis M
Project Start
1980-04-01
Project End
2003-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
20
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Jackson, Lydgia A; Drevets, Douglas A; Dong, Zhao-Ming et al. (2005) Levels of L-selectin (CD62L) on human leukocytes in disseminated cryptococcosis with and without associated HIV-1 infection. J Infect Dis 191:1361-7
Blackstock, Rebecca; Murphy, Juneann W (2004) Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells. Infect Immun 72:5175-80
Bauman, Sean K; Huffnagle, Gary B; Murphy, Juneann W (2003) Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 71:68-74
Nichols, Kasie L; Bauman, Sean K; Schafer, Fredda B et al. (2002) Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans. Infect Immun 70:591-600
Bauman, S K; Nichols, K L; Murphy, J W (2000) Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol 165:158-67
McGaha, T; Murphy, J W (2000) CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect Immun 68:4624-30
Blackstock, R; Buchanan, K L; Cherniak, R et al. (1999) Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 147:1-11
Doyle, H A; Murphy, J W (1999) Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response. J Immunol 162:4824-33
Blackstock, R; Buchanan, K L; Adesina, A M et al. (1999) Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 67:3601-9
Huffnagle, G B; McNeil, L K; McDonald, R A et al. (1999) Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 163:4642-6

Showing the most recent 10 out of 37 publications